Not a good buy right now for an impatient entry: price is trading below/near key support with bearish momentum and no Intellectia buy signals.
Bullish medium-term narrative (pivot to HPC/AI hosting) and strong Wall Street upgrades are positives, but near-term tape is weak and recent fundamentals show deteriorating profitability.
If you must act immediately, this is better treated as a speculative bounce setup only near stronger support (~15.38) rather than buying at ~16.2 pre-market.
Technical Analysis
Trend/Momentum: MACD histogram is negative (-0.254) and expanding downward → bearish momentum still building.
RSI: RSI(6) ~21 suggests oversold conditions (bounce risk), but oversold alone is not a buy trigger without confirmation.
Moving averages: converging MAs indicate consolidation, but current momentum favors downside continuation until reclaiming the pivot.
Levels: Support S1 ~16.40 (price ~16.19 pre-market is below/pressing it), next support S2 ~15.38; resistance/pivot ~18.06, then R1 ~19.72.
Probabilistic pattern read: similar-pattern study implies mild downside drift (next month ~-3.3%), which aligns with the bearish MACD.
Sentiment: Put/Call ratios are very low (OI PCR 0.34; Volume PCR 0.21) → options flow is skewed bullish/call-heavy.
Activity: Today’s volume ~120,832 and ~108% of 30D average → elevated participation.
Volatility: IV30 ~107% vs HV ~56% with IV percentile ~89 → options are expensive; market is pricing large moves.
Takeaway: Options market is leaning bullish, but the high IV suggests you’re paying up for that optimism (and it often coincides with choppy price action).
Technical Summary
Sell
6
Buy
10
Positive Catalysts
can support incremental demand.
Neutral/Negative Catalysts
raises odds of a move toward S2 (~15.
before any durable rebound.
Financial Performance
Latest quarter provided: 2025/Q3.
Revenue: $81.10M, down ~14.95% YoY → top-line contraction.
Net income: -$147.51M (loss widened vs YoY by ~57% on the provided metric) → profitability deteriorated.
EPS: -0.46, down ~60.68% YoY → earnings trend negative.
Gross margin: 4.81%, sharply down YoY → weak unit economics/transition costs still evident.
Bottom line: the financials reflect a company still in a difficult transition phase; the bull case relies on forward HPC ramp, not current-quarter strength.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: clear improvement—multiple upgrades/raised targets in Dec 2025–Jan 2026 (targets lifted into the ~$23–$30 range).
Wall Street pros: strong perceived upside from HPC/AI infrastructure demand; view that CORZ can sign additional colocation/HPC leases beyond CoreWeave and re-rate as an HPC infrastructure provider.
Wall Street cons: near-term financial weakness and transition/execution risk; shares can remain headline-driven until contract pipeline converts into cleaner revenue/margins.
Wall Street analysts forecast CORZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CORZ is 27.46 USD with a low forecast of 19.94 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
Wall Street analysts forecast CORZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CORZ is 27.46 USD with a low forecast of 19.94 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Buy
1 Hold
0 Sell
Strong Buy
Current: 14.815
Low
19.94
Averages
27.46
High
40
Current: 14.815
Low
19.94
Averages
27.46
High
40
Keefe Bruyette
Outperform
maintain
$19 -> $25
AI Analysis
2026-01-26
Reason
Keefe Bruyette
Price Target
$19 -> $25
AI Analysis
2026-01-26
maintain
Outperform
Reason
Keefe Bruyette raised the firm's price target on Core Scientific to $25 from $19 and keeps an Outperform rating on the shares. The firm updated the company's model ahead of the Q4 report. Core Scientific is "executing a full pivot" from bitcoin mining to high performance compute leasing, yet the shares are valued largely on the existing CoreWeave leases, the analyst tells investors in a research note. Keefe sees an attractive setup for the shares ahead of expected pipeline updates and new deals from Core Scientific.
BTIG
Gregory Lewis
Neutral -> Buy
upgrade
$23
2026-01-06
Reason
BTIG
Gregory Lewis
Price Target
$23
2026-01-06
upgrade
Neutral -> Buy
Reason
BTIG analyst Gregory Lewis upgraded Core Scientific (CORZ) to Buy from Neutral with a $23 price target. The firm says the "dust settled" following Core Scientific's shareholder rejection of its merger with CoreWeave (CRWV). Core Scientific has been one of the worst performing stocks that have a signed contract to convert at least some power infrastructure away from crypto mining to high performance compute, the analyst tells investors in a research note. BTIG expects the company to "hit the ground running" in 2026, securing additional HPC colocation contracts, saying power infrastructure for compute remains strong.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CORZ
